PFIZER DAPTOMYCIN daptomycin 500 mg powder for injection vial, Pfizer Australia Pty Ltd, CON-1179

1. A Dear Healthcare Provider' letter identical to that provided to the Therapeutics Goods Administration on 6 November 2023 will be supplied with the affected batch describing the differences between the approved label and the supplied label and any precautions the user needs to take. 2. The labels to be supplied are those included with the application dated 6 November 2023. The label will include the information on the over-sticker.